Vident Advisory’s Manhattan Associates MANH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.44M Buy
18,300
+9,473
+107% +$1.42M 0.02% 566
2025
Q4
$1.53M Sell
8,827
-957
-10% -$175K 0.01% 654
2025
Q3
$2.01M Sell
9,784
-4,612
-32% -$975K 0.02% 577
2025
Q2
$2.84M Buy
14,396
+1,688
+13% +$306K 0.03% 410
2025
Q1
$2.2M Buy
12,708
+160
+1% +$33.3K 0.03% 449
2024
Q4
$3.39M Sell
12,548
-18
-0.1% -$5.13K 0.06% 293
2024
Q3
$3.54M Sell
12,566
-4,709
-27% -$1.2M 0.09% 230
2024
Q2
$4.26M Buy
17,275
+849
+5% +$193K 0.12% 171
2024
Q1
$4.11M Sell
16,426
-823
-5% -$196K 0.09% 238
2023
Q4
$3.71M Buy
17,249
+1,230
+8% +$260K 0.09% 238
2023
Q3
$3.17M Buy
+16,019
New +$3.13M 0.1% 217

Other funds holding MANH

Vident Advisory's MANH Position: Q1 2026 in Review

Vident Advisory increased its Manhattan Associates (MANH) stake by 107% in Q1 2026, buying an estimated $1.42M and bringing the position to 18,300 shares worth $2.44M. The position accounts for 0.02% of the portfolio, ranked #566.

Vident Advisory first reported a position in MANH in Q3 2023 and has held it in 11 quarters since. The position peaked at $4.26M in Q2 2024. 526 funds tracked by Wall St. Rank hold MANH as of Q1 2026.

  • Vident Advisory held 18,300 shares of Manhattan Associates worth $2.44M as of Q1 2026.
  • Vident Advisory bought 9,473 Manhattan Associates shares in Q1 2026, an estimated $1.42M.
  • Manhattan Associates made up 0.02% of Vident Advisory's portfolio in Q1 2026, its #566 holding.
  • Vident Advisory first reported a position in Manhattan Associates in Q3 2023 and has held it in 11 quarters since.
  • Vident Advisory's Manhattan Associates position peaked at $4.26M in Q2 2024.
  • 526 funds tracked by Wall St. Rank held Manhattan Associates as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.